{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:54:11Z","timestamp":1782752051885,"version":"3.54.5"},"reference-count":72,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>The involvement of the knee joint is the most common localization of the pathological process in osteoarthritis (OA), which is associated with obesity in over 50% of the patients and is mediated by mechanical, inflammatory, and metabolic mechanisms. Obesity and the associated conditions (hyperglycemia, dyslipidemia, and hypertension) have been found to be risk factors for the development of knee OA, which has led to the emerging concept of the existence of a distinct phenotype, i.e., metabolic knee OA. Combined assessment of markers derived from dysfunctional adipose tissue, markers of bone and cartilage metabolism, as well as high-sensitivity inflammatory markers and imaging, might reveal prognostic signs for metabolic knee OA. Interestingly, it has been suggested that drugs used for the treatment of other components of the metabolic syndrome may also affect the clinical course and retard the progression of metabolic-associated knee OA. In this regard, significant amounts of new data are accumulating about the role of metformin\u2014a drug, commonly used in clinical practice with suggested multiple pleiotropic effects. The aim of the current review is to analyze the current views about the potential pleiotropic effects of metformin in OA. Upon the analysis of the different effects of metformin, major mechanisms that might be involved in OA are the influence of inflammation, oxidative stress, autophagy, adipokine levels, and microbiome modulation. There is an increasing amount of evidence from in vitro studies, animal models, and clinical trials that metformin can slow OA progression by modulating inflammatory and metabolic factors that are summarized in the current up-to-date review. Considering the contemporary concept about the existence of metabolic type knee OA, in which the accompanying obesity and systemic low-grade inflammation are suggested to influence disease course, metformin could be considered as a useful and safe component of the personalized therapeutic approach in knee OA patients with accompanying type II diabetes or obesity.<\/jats:p>","DOI":"10.3390\/life13020437","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T04:08:07Z","timestamp":1675656487000},"page":"437","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pleiotropic Effects of Metformin in Osteoarthritis"],"prefix":"10.3390","volume":"13","author":[{"given":"Sevdalina Nikolova","family":"Lambova","sequence":"first","affiliation":[{"name":"Department of Propaedeutics of Internal Diseases \u201cProf Dr Anton Mitov\u201d, Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria"},{"name":"Department in Rheumatology, MHAT \u201cSveti Mina\u201d, 4002 Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13075-019-1915-x","article-title":"Association between metformin use and disease progression in obese people with knee osteoarthritis: Data from the Osteoarthritis Initiative\u2014A prospective cohort study","volume":"21","author":"Wang","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/postgradmedj-2013-203726rep","article-title":"Value of biomarkers in osteoarthritis: Current status and perspectives","volume":"90","author":"Lotz","year":"2014","journal-title":"Postgrad. Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1759720X12467868","article-title":"Role of inflammation in the pathogenesis of osteoarthritis: Latest findings and interpretations","volume":"5","author":"Sokolove","year":"2013","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"Berenbaum","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.joca.2017.02.791","article-title":"ADAMTS and ADAM metalloproteinases in osteoarthritis\u2014Looking beyond the \u2018usual suspects","volume":"25","author":"Yang","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/art.11303","article-title":"Evidence for a Key Role of Leptin in Osteoarthritis","volume":"48","author":"Dumond","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar3283","article-title":"Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine","volume":"13","author":"Ivanovska","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0363546514533777","article-title":"Chondroprotection and the prevention of osteoarthritis progression of the knee: A systematic review of treatment agents","volume":"43","author":"Gallagher","year":"2015","journal-title":"Am. J. Sport. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.medntd.2020.100052","article-title":"Metabolic syndrome and osteoarthritis: Possible mechanisms and management strategies","volume":"9","author":"Tan","year":"2021","journal-title":"Med. Nov. Technol. Devices"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lambova, S.N., Batsalova, T., Moten, D., Stoyanova, S., Georgieva, E., Belenska-Todorova, L., Kolchakova, D., and Dzhambazov, B. (2021). Serum leptin and resistin levels in knee osteoarthritis\u2014Clinical and radiologic links: Towards precise definition of metabolic type knee osteoarthritis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9081019"},{"key":"ref_12","first-page":"88","article-title":"Patellofemoral Pain Syndrome","volume":"99","author":"Gaitonde","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4081\/reumatismo.2019.1231","article-title":"Don\u2019t forget the jumper\u2019s knee in the young sportsman: Evaluation of patellar tendinopathy with a high frequency ultrasound probe B","volume":"71","author":"Ruaro","year":"2019","journal-title":"Reumatismo"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/1941738116681269","article-title":"How to Deal With Anterior Knee Pain in the Active Young Patient","volume":"9","author":"Dye","year":"2017","journal-title":"Sport. Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5312\/wjo.v5.i3.319","article-title":"Adipokines: Biomarkers for osteoarthritis?","volume":"5","author":"Poonpet","year":"2014","journal-title":"World J. Orthop."},{"key":"ref_16","first-page":"1221","article-title":"The association of obesity with osteoarthritis of the hand and knee in women: A twin study","volume":"23","author":"Cicuttini","year":"1996","journal-title":"J. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1532164","DOI":"10.1155\/2019\/1532164","article-title":"An update on the emerging role of resistin on the pathogenesis of osteoarthritis","volume":"2019","author":"Zhao","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1007\/s11033-009-9911-x","article-title":"Leptin plays a catabolic role on articular cartilage","volume":"37","author":"Bao","year":"2010","journal-title":"Mol. Biol. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jpain.2015.09.004","article-title":"Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers","volume":"16","author":"Martin","year":"2015","journal-title":"J. Pain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/acr.23091","article-title":"Association of beta-blocker use with less prevalent joint pain and lower opioid requirement in people with osteoarthritis","volume":"69","author":"Valdes","year":"2017","journal-title":"Arthritis Care Res."},{"key":"ref_21","first-page":"12584","article-title":"Captopril, an angiotensin-converting enzyme inhibitor, possesses chondroprotective efficacy in a rat model of osteoarthritis through suppression local renin-angiotensin system","volume":"8","author":"Tang","year":"2015","journal-title":"J. Clin. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/annrheumdis-2016-eular.2888","article-title":"Does renin-angiotensin-aldosterone system blockade influence pain, function and radiographic progression in knee osteoarthritis? An analysis of Osteoarthritis Initiative data","volume":"75","author":"Shirinsky","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Belenska-Todorova, L., Lambova, S.N., Stoyanova, S., Georgieva, E., Batsalova, T., Moten, D., Kolchakova, D., and Dzhambazov, B. (2021). Disease-modifying potential of metformin and alendronate in an experimental mouse model of osteoarthritis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9081017"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5114\/aoms.2012.31622","article-title":"Metformin and its clinical use: New insights for an old drug in clinical practice","volume":"8","author":"Cicero","year":"2012","journal-title":"Arch. Med. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin-Mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.arr.2018.10.003","article-title":"Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing","volume":"48","author":"Prattichizzo","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00228-018-2593-3","article-title":"Role of metformin in overweight and obese people without diabetes: A systematic review and network meta-analysis","volume":"75","author":"Hui","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/humupd\/8.5.449","article-title":"Ovulation induction in perspective","volume":"8","author":"Homburg","year":"2002","journal-title":"Hum. Reprod. Update"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3389\/fendo.2019.00617","article-title":"The potential effect of metformin on cancer: An umbrella review","volume":"10","author":"Yu","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"952560","DOI":"10.3389\/fphar.2022.952560","article-title":"The effects of metformin in the treatment of osteoarthritis: Current perspectives","volume":"13","author":"Song","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"He, M., Lu, B., Opoku, M., Zhang, L., Xie, W., Jin, H., Chen, S., Li, Y., and Deng, Z. (2022). Metformin Prevents or Delays the Development and Progression of Osteoarthritis: New Insight and Mechanism of Action. Cells, 11.","DOI":"10.3390\/cells11193012"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2443.2003.00615.x","article-title":"A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway","volume":"8","author":"Kimura","year":"2003","journal-title":"Genes Cells"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/art.30333","article-title":"Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1\u03b2 and tumor necrosis factor \u03b1","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.5582\/bst.2018.01263","article-title":"Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1\/Parkin-dependent mitophagy in primary chondrocytes","volume":"12","author":"Wang","year":"2018","journal-title":"Biosci. Trends"},{"key":"ref_35","first-page":"632","article-title":"Metformin protects chondrocytes against IL-1\u03b2 induced injury by regulation of the AMPK\/NF-\u03baB signaling pathway","volume":"75","author":"Zhang","year":"2020","journal-title":"Pharmazie"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.biocel.2013.08.018","article-title":"The NF-\u03baB signalling pathway in osteoarthritis","volume":"45","author":"Rigoglou","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.biopha.2018.11.032","article-title":"Metformin; an old antidiabetic drug with new potentials in bone disorders","volume":"109","author":"Bahrambeigi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_38","first-page":"e28462","article-title":"Role of metformin in the management of polycystic ovarian syndrome-associated acne: A systematic review","volume":"14","author":"Shamim","year":"2022","journal-title":"Cureus"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"155160","DOI":"10.1016\/j.metabol.2022.155160","article-title":"Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure","volume":"130","author":"Schernthaner","year":"2022","journal-title":"Metabolism"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000381643","article-title":"Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium","volume":"24","author":"Kinaan","year":"2015","journal-title":"Med. Princ. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2337\/diabetes.51.1.189","article-title":"The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation","volume":"51","author":"Standeven","year":"2002","journal-title":"Diabetes"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2006.02.030","article-title":"Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture","volume":"536","author":"Cortizo","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","article-title":"Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats","volume":"112","author":"Mai","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1359\/jbmr.080323","article-title":"Fracture risk in type 2 diabetes: Update of a population-based study","volume":"23","author":"Melton","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3892\/ijo.2013.2077","article-title":"Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway","volume":"43","author":"Yi","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13813450801969715","article-title":"The role of insulin receptors and IGF-I receptors in cancer and other diseases","volume":"114","author":"Frasca","year":"2008","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4110\/in.2013.13.4.123","article-title":"Metformin Down-regulates TNF-\u03b1 Secretion via Suppression of Scavenger Receptors in Macrophages","volume":"13","author":"Hyun","year":"2013","journal-title":"Immune Netw."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-016-0142-3","article-title":"Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes","volume":"13","author":"Chen","year":"2016","journal-title":"J. Inflamm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clnu.2012.08.006","article-title":"Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: A randomized clinical trial","volume":"32","author":"Esteghamati","year":"2013","journal-title":"Clin. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.18632\/aging.102635","article-title":"Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK\/mTOR","volume":"12","author":"Feng","year":"2020","journal-title":"Aging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cell.2013.02.035","article-title":"Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism","volume":"153","author":"Cabreiro","year":"2013","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1677\/joe.1.05646","article-title":"Metformin inhibits leptin secretion via a mitogen-activated protein kinase signalling pathway in brown adipocytes","volume":"183","author":"Klein","year":"2004","journal-title":"J. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1053\/meta.2001.28078","article-title":"Beneficial effects of metformin in normoglycemic morbidly obese adolescents","volume":"50","author":"Kay","year":"2001","journal-title":"Metab.-Clin. Exp."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2020.110452","article-title":"Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols","volume":"129","author":"Ansari","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"558474","DOI":"10.3389\/fphar.2020.558474","article-title":"Metformin: A Prospective Alternative for the Treatment of Chronic Pain","volume":"11","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12974-019-1411-x","article-title":"AMPK activation attenuates inflammatory pain through inhibiting NF-\u03baB activation and IL-1\u03b2 expression","volume":"16","author":"Xiang","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.neuroscience.2010.05.067","article-title":"Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation","volume":"169","author":"Codeluppi","year":"2010","journal-title":"Neuroscience"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuroscience.2017.07.020","article-title":"Pharmacological activation of AMPK inhibits incision-evoked mechanical hypersensitivity and the development of hyperalgesic priming in mice","volume":"359","author":"Burton","year":"2017","journal-title":"Neuroscience"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/jnc.15172","article-title":"Oncostatin M induces hyperalgesic priming and amplifies signaling of cAMP to ERK by RapGEF2 and PKA","volume":"157","author":"Ebersberger","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"219625","DOI":"10.1155\/2012\/219625","article-title":"Autophagy: More than a nonselective pathway","volume":"2012","author":"Reggiori","year":"2012","journal-title":"Int. J. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"103904","DOI":"10.1016\/j.jff.2020.103904","article-title":"Crosstalk between gut microbiota and osteoarthritis: A critical view","volume":"68","author":"Korotkyi","year":"2020","journal-title":"J. Funct. Foods"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.41210","article-title":"Identification of Cartilage Microbial DNA Signatures and Associations with Knee and Hip Osteoarthritis","volume":"72","author":"Dunn","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.joca.2015.03.014","article-title":"Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: Studies in a rat model","volume":"23","author":"Collins","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e0257","DOI":"10.1097\/MD.0000000000010257","article-title":"The role of leptin in osteoarthritis","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bcpt.12160","article-title":"Leptin\u2014A link between obesity and osteoarthritis. Applications for prevention and treatment","volume":"114","author":"Vuolteenaho","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4049\/jimmunol.1800006","article-title":"Metformin Augments Anti-Inflammatory and Chondroprotective Properties of Mesenchymal Stem Cells in Experimental Osteoarthritis","volume":"203","author":"Park","year":"2019","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3389\/fphar.2020.01114","article-title":"Metformin Mitigates Cartilage Degradation by Activating AMPK\/SIRT1-Mediated Autophagy in a Mouse Osteoarthritis Model","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Na, H.S., Kwon, J.Y., Lee, S.Y., Lee, S.H., Lee, A.R., Woo, J.S., Jung, K., Cho, K.-H., Choi, J.-W., and Lee, D.H. (2021). Metformin attenuates monosodium-iodoacetate-induced osteoarthritis via regulation of pain mediators and the autophagy\u2013lysosomal pathway. Cells, 10.","DOI":"10.3390\/cells10030681"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1004S","DOI":"10.1177\/1947603520962558","article-title":"The Effect of Body Mass Index and Metformin on Matrix Gene Expression in Arthritic Primary Human Chondrocytes","volume":"13","author":"Schadler","year":"2021","journal-title":"Cartilage"},{"key":"ref_71","first-page":"13","article-title":"Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score","volume":"23","author":"Mohammed","year":"2014","journal-title":"Iraqi J. Pharm. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lu, C.-H., Chung, C.-H., Lee, C.-H., Hsieh, C.-H., Hung, Y.-J., Lin, F.-H., Tsao, C.-H., Hsieh, P.-S., and Chien, W.-C. (2018). Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191242"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/2\/437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:23:38Z","timestamp":1760120618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/2\/437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":72,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["life13020437"],"URL":"https:\/\/doi.org\/10.3390\/life13020437","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}